|Elder Care Zone - Caring for the Elderly
(Add to Favorites | View All Articles | Resource Directory)
Breakthrough in Alzheimers Research
New Hope for Alzheimers Treatment
There is now widespread agreement among research scientists and medical professionals that Alzheimer's Disease (AD) is a problem quickly growing to vast proportions. As the life expectancy of Americans continues to rise, increasing the percentage of the population over 65 years of age, so does the number of Alzheimer's cases.
It is currently estimated that people over 65 years of age have a 10% chance of developing Alzheimer's, while those over 85 have a 50% likelihood of developing AD, making it the leading cause of dementia among older people. Though the disease is associated primarily with memory loss, its effects also comprise a number of other severe disabilities, including changes in personality, disorientation, difficulty with speech and comprehension, and a lack of ability to move normally.
Consequently, most Alzheimer's patients require a great deal of care, costing society close to $100 billion annually. According to Christian Fritze, Ph.D., Director of the Antibody Products Division at Covance Research Products, "The impact of Alzheimer's Disease on our society will only increase as our population ages. The prevalence of the disease and disabling effects on the patient are significant by themselves. In addition we are becoming increasingly aware of the far-reaching effects on families, care-giver networks and the economics of our health care system. The drive for progress towards effective treatments by the research and drug development community is growing stronger every day."
A New Consensus
But recent developments in the medical research community do provide some hope. During the last two years, there has been a growing consensus among Alzheimer researchers about the cause of Alzheimer's disease, providing focus for scientists exploring the new treatment options.
The focus is on amyloid beta oligomers, a new wrinkle on an older hypothesis called the "amyloid cascade hypothesis". Widespread acceptance of this new conclusion is something of a milestone in the history of Alzheimer's research. As Dr. Fritze says, "The decades old quest for the causative agent in Alzheimer's Disease has recently focused on the precursors of amyloid plaques. These precursors are part of a bewildering array of processed (APP) Amyloid Precursor Protein) variants, Tau isoforms and secretase components that play a role in neuronal cytotoxicity and subsequent brain dysfunction."
Amyloid plaques are sticky protein deposits in the brain containing amyloid beta peptide. Researchers have associated the buildup of this plaque with Alzheimer's disease since its discovery in 1907. But despite the clear correlation, scientists were not sure what, exactly, spurred the onset of Alzheimer's Disease.
The hypothesis that amyloid beta accumulation in the brain is the major cause of Alzheimer's Disease1 has been the focus of much attention over the past decade. Although this hypothesis was the leading explanation for the cause of AD, it had several weaknesses. The most obvious problem with the theory was the fact that the buildup of amyloid beta peptides did not necessarily correspond with the severity of Alzheimer's symptoms.
However, in 19982 and in 20023, researchers proposed that it was not the amyloid beta plaques themselves that were neurotoxic - and therefore the cause of Alzheimer's - but rather precursors to amyloid beta plaques formed by smaller aggregates of amyloid beta. These new ideas are gaining widespread acceptance among the Alzheimer's research community, creating a consensus that had not existed before.
This new focus provides one more spur to action for Alzheimer's researchers, and underscores the need for further advancement. "The AD field demands sophisticated, highly-sensitive research tools to track these components and quantitate the existence of monomeric, oligomeric and fibrillar amyloid forms present in the progression of Alzheimer's disease," says Dr. Fritze.
Two new studies, both released in October 20044, suggest that new treatment options may be on the horizon. The studies are the modification of one of two previous attempts using amyloid beta (Aβ) antibodies in the treatment of Alzheimer's Disease. The previous attempts, though not successful, did at least suggest new courses of action in Alzheimer's research and provided invaluable information for researchers.
In the first of the two previous attempts, researchers injected the antigen itself - pieces of the beta amyloid protein that makes up amyloid plaque - into mice, in the hopes that the injections would generate an immune (antibody) response against amyloid. Results were initially positive. The injected antigen produced Aβ antibodies and slowed the onset of the disease by decreasing Aβ levels. However, when tried on humans, the procedure led to meningoencephalitis (an inflammation of tissue around the brain) in some patients, and was therefore halted.
In the second attempt, a passive immunity therapy was tried in which antibodies to amyloid beta (not amyloid protein) were injected into mice, but hemorrhaging and inflammation ensued due to the high antibody doses required to be effective.
But now there appears to be new hope for the use of antibodies as therapeutic agents for the treatment of Alzheimer's patients. In the first of the two new studies that appeared in October conducted by the National Institute for Longevity Sciences, NCGG, and the Center for Neurological Diseases, Brigham & Women's College, Harvard Institute of Medicine, researchers modified the first procedure. Concluding that the meningoenchaphalitis which occurred in some patients was caused by autoimmune T-cell activation, the researchers hoped to develop a vaccine that could minimize this T-cell activation while retaining the production of Aß antibodies.
To accomplish this they created an oral vaccine that attached Aß DNA to an adeno-associated virus vector, which served to mitigate T-cell activation. Thus they were able to decrease Aß levels in the brains of the mice and yet not activate T-cells to the degree they had before, greatly reducing the risk of meningoencephalitis.
In the other new study, conducted at the University of Illinois at Chicago, researchers succeeded in making the passive immunity protocol much safer. This they accomplished by changing the point of entry for the Aß antibodies. Rather than injecting the antibodies into the body of the mice, as was done previously, antibody was injected directly into the brain of the mice. Because the antibodies were injected directly into the brain, smaller doses were needed, and side effects were minimized.
The results of the above studies, and the potential for further optimized immunization strategies may prove to be watershed events in the history of Alzheimer's treatment.
Covance is a leading provider of innovative antibody products and custom antibody development services to the research community for Alzheimer's disease. Visit www.Covance.com for more in-depth information and to view the suite of products for Alzheimer's disease. Boris Predovich is Vice President of Immunology and Surgical Services at Covance Research Products.
1. J.A. Hardy, G.A. Higgins (1992), Science, 256:184-5.
R. L. Fielding writes on many health-related topics.
4 min 25 sec ago
0 sec ago
Two-fifths of U.S. adults care for sick, elderly relatives
Medline Sponsors National Conference to Honor Caregivers of Our Nation's Elderly
Charge for some NHS services as part of shake-up of health and elderly care ... - Telegraph.co.uk
9 sec ago
While standing in line for a prescription...
I finally went to the doctor this morning for my bad cold. My appointment was for 9:30 am and yet I didn't get home until after 1:00 pm.
Arizona Assisted Living: Resident Rights
According to the Arizona Administrative Code (R9-10-710), those who reside in assisted living facilities in Arizona have certain rights. In addition to having the right to live in an environment that promotes dignity, independence, self-determination, individuality, privacy and the right of choice, the following are a few of the rights given to residents who reside in assisted living facilities:1.
Care Givers - How to avoid burnout
Just for a moment I want you to imagine that you are coming out of a very deep sleep. If you have ever had surgery try to remember the way you felt as you were trying to make sense of things as you awoke.
Do some research before buying any Stair Lift
There is no doubt that having a stair lift in your home can dramatically improve your quality of life. If you are starting to find that climbing the stairs is becoming a hazardous experience, or just hard work, then a stair lift could be the answer.
Caregiving Across The Miles-Tips for Successful Long Distance Caregiving
Caring for a parent or a loved one is a difficult job. Your duties as a caregiver become increasingly difficult as the miles increase between you and your loved one.
Angels are for everyone
I am reminded time after time of the profound effect Angels have on people. Recently, I have been receiving many emails containing examples of how the Angels are reaching through the veils to assist the elderly.
Assisted Living - Combatting Patient Loneliness
Q: Six months ago we placed my mother in an assisted living facility. She gets along fairly well, but we thought she would get involved with all of the activities.
Assisted Living - Nursing Homes are not the only answer
The cost of skilled nursing care is slowly rising. Currently, the average cost of care in Arizona ranges from $3,500 to $4,500 per month.
Arizona Senior Housing: Care Options for Seniors Who Can No Longer Live Alone
The following are a few of the care options available for seniors who can no longer live on their own and require assistance with their Activities of Daily Living (ADL), or require skilled nursing care. Every state is a little different in terms of availability and cost, state regulations, and the specific names used for each care option:Assisted Living Home- A facility consisting of 10 or fewer residents in a private home setting located in residential neighborhoods.
Alzheimers treatment facilities
As a person ages, a certain amount of memory loss and confusion is quite normal. Personally, I've been known to invoke the cliché, "The older I get, the better I was!" Unfortunately, Alzheimer's disease represents a more serious loss of mental sharpness and calls for special care for seniors.
Psychologists: May be more effective than drugs, and covered by Medicare!
Medicare recognizes this need and, therefore reimburses your residents to receive advanced behavioral health services? making them free to your facility!Psychologists provide a wide variety of valuable and tested clinical services that can provide a big shot in the arm to your nursing home care. For example:1.
Prevent many chronic age-related illnesses by adding Protein
Youth, it is said, is wasted on the young. Too busy figuring life they hardly take the time to enjoy it.
Stair Lifts - A quick look
Buying a stairlift can have huge benefits for your quality of life, giving you back some freedom and independence. Stairlifts can be adapted to your individual needs, so no matter what your requirements are, there'll be one to suit you.
Wheelchair accessories can make life easier and more comfortable
Wheelchairs come in every shape and size with sufficient options that you can find the wheels you like to take you where you want to go with the assistance you need. To enhance the comfort and convenience of your journey, choose accessories tailored to provide the best support for your activities and your health concerns.
Long-Term Care Insurance - What to look for when shopping
We will all grow old; this is a given. We will all have health issues as we grow older, this also is a given.
Housing for lower income seniors who are able to care for themselves
A few years ago Miranda M. became a widow.
As the Baby Boomers Age
Many employees today are calling in sick - not to care for themselves or their children, but to care for their aging parents. Baby boomers are rapidly moving into the role of caregivers for their parents, but with a few extra challenges due to the changing face of our workforce.
Long term Care Insurance - Probably the most important asset you could ever own
If you're 60 to 70 years old ..
How far does a child's responsibility to care for their parents go?
It happens somewhat slowly in the beginning, maybe with a small cough that gets worse as time goes on. It might simply begin with absent mindedness which is totally out of character, followed by total memory lapses.
Adding sparkle to an Alzheimers patient's life
Severe degradation of short-term memory means that my father, an Alzheimer's elder, is seldom interested in movies or books. And, although music used to be a source of enjoyment, he no longer listens with pleasure.
|Home | Site Map | Privacy Statement | More Articles|